Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
171
datasets available to search
ShareScore release 0.9.0
Dataset results
171 results for “K-12”
RNA-seq analysis of Escherichia coli str. K-12 substr. MG1655
GEO Series GSE45443. Escherichia coli str. K-12 substr. MG1655. 54 samples. Type: Expression profiling by high throughput sequencing.
Expression analysis of Escherichia coli MG1655 K-12 WT and ∆fnr mutant
GEO Series GSE41189. Escherichia coli K-12; Escherichia coli str. K-12 substr. MG1655star. 6 samples. Type: Expression profiling by array.
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and mutant E. coli K-12 MG1655 Transcriptomes
GEO Series GSE107048. Escherichia coli str. K-12 substr. MG1655. 12 samples. Type: Expression profiling by high throughput sequencing.
Revealing the genome-scale transcriptional regulatory landscape of OmpR highlights its expanded regulatory roles and unexpected importance of narU under osmotic stress in Escherichia coli K-12 MG1655
GEO Series GSE88981. Escherichia coli str. K-12 substr. MG1655. 6 samples. Type: Genome binding/occupancy profiling by high throughput sequencing; Expression profiling by high throughput sequencing.
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and carbamazepine-stressed E. coli K-12 LE392, P. putida KT2440, and RP4 plasmid Transcriptomes
GEO Series GSE112064. Pseudomonas putida; Escherichia coli. 12 samples. Type: Expression profiling by high throughput sequencing.
Expression profiling of E. coli K-12 MG1655
GEO Series GSE122211. Escherichia coli str. K-12 substr. MG1655; Escherichia coli BW25113. 12 samples. Type: Expression profiling by high throughput sequencing.
A comparison between two Escherichia coli K-12 MG1655 substrains possessing different swimming motility
GEO Series GSE165438. Escherichia coli str. K-12 substr. MG1655. 4 samples. Type: Expression profiling by high throughput sequencing.
Figure 4 from: Abdullah T, Al-Kinani K (2024) Propranolol nanoemulgel: Preparation, in-vitro and ex-vivo characterization for a potential local hemangioma therapy. Pharmacia 71: 1-12. https://doi.org/10.3897/pharmacia.71.e115330
Figure 4 The impact of the Km ratio on globule size and PDI of the generated NEs.
Figure A2 from: Abdullah T, Al-Kinani K (2024) Propranolol nanoemulgel: Preparation, in-vitro and ex-vivo characterization for a potential local hemangioma therapy. Pharmacia 71: 1-12. https://doi.org/10.3897/pharmacia.71.e115330
Figure A2 Photographic pictures displaying the dilutability of PHCl-NEs.
Figure 8 from: Abdullah T, Al-Kinani K (2024) Propranolol nanoemulgel: Preparation, in-vitro and ex-vivo characterization for a potential local hemangioma therapy. Pharmacia 71: 1-12. https://doi.org/10.3897/pharmacia.71.e115330
Figure 8 Spreadability values for the PHCl-NEG compared to the marketed product.
Figure 3 from: Abdullah T, Al-Kinani K (2024) Propranolol nanoemulgel: Preparation, in-vitro and ex-vivo characterization for a potential local hemangioma therapy. Pharmacia 71: 1-12. https://doi.org/10.3897/pharmacia.71.e115330
Figure 3 Pseudo-ternary phase diagrams of PHCl-NEs at various Km ratios.
Figure A1 from: Abdullah T, Al-Kinani K (2024) Propranolol nanoemulgel: Preparation, in-vitro and ex-vivo characterization for a potential local hemangioma therapy. Pharmacia 71: 1-12. https://doi.org/10.3897/pharmacia.71.e115330
Figure A1 Specimen of skin from Wister Albino rat.
Figure 1 from: Abdullah T, Al-Kinani K (2024) Propranolol nanoemulgel: Preparation, in-vitro and ex-vivo characterization for a potential local hemangioma therapy. Pharmacia 71: 1-12. https://doi.org/10.3897/pharmacia.71.e115330
Figure 1 Histogram of PHCl solubility in different oils.
Figure 6 from: Abdullah T, Al-Kinani K (2024) Propranolol nanoemulgel: Preparation, in-vitro and ex-vivo characterization for a potential local hemangioma therapy. Pharmacia 71: 1-12. https://doi.org/10.3897/pharmacia.71.e115330
Figure 6 Surface 3D view of PHCl-NE3 by AFM.
Figure 5 from: Abdullah T, Al-Kinani K (2024) Propranolol nanoemulgel: Preparation, in-vitro and ex-vivo characterization for a potential local hemangioma therapy. Pharmacia 71: 1-12. https://doi.org/10.3897/pharmacia.71.e115330
Figure 5 In-vitro drug diffusion profiles of PHCl-NEs (NE2 and NE3).
Figure 2 from: Abdullah T, Al-Kinani K (2024) Propranolol nanoemulgel: Preparation, in-vitro and ex-vivo characterization for a potential local hemangioma therapy. Pharmacia 71: 1-12. https://doi.org/10.3897/pharmacia.71.e115330
Figure 2 Chemical structure of PHCl.
Figure 3 from: Ananda N, Sabina A, Rahmadani U, Syahrizal A, Deskya N, Maria S, Riza M, Rahmadia L, Holila A, Putri D, Gabriel K, Zai RS, Carensia M, Halim P, Regina N, Rizka D, Syahfitri A, Rotua T, Belen M, Nanda F, Pramuditya R, Khairunnisa K, Salim E, Nurkolis F, Umaya C, Abdi Syahputra R (2024) Malaria's molecular dance: Mechanism, therapies, and emerging insights. Pharmacia 71: 1-12. https://doi.org/10.3897/pharmacia.71.e117145
Figure 3 Vaccine develop stargety.
Figure 1 from: Ananda N, Sabina A, Rahmadani U, Syahrizal A, Deskya N, Maria S, Riza M, Rahmadia L, Holila A, Putri D, Gabriel K, Zai RS, Carensia M, Halim P, Regina N, Rizka D, Syahfitri A, Rotua T, Belen M, Nanda F, Pramuditya R, Khairunnisa K, Salim E, Nurkolis F, Umaya C, Abdi Syahputra R (2024) Malaria's molecular dance: Mechanism, therapies, and emerging insights. Pharmacia 71: 1-12. https://doi.org/10.3897/pharmacia.71.e117145
Figure 1 Malaria cases in the world.
Figure 2 from: Ananda N, Sabina A, Rahmadani U, Syahrizal A, Deskya N, Maria S, Riza M, Rahmadia L, Holila A, Putri D, Gabriel K, Zai RS, Carensia M, Halim P, Regina N, Rizka D, Syahfitri A, Rotua T, Belen M, Nanda F, Pramuditya R, Khairunnisa K, Salim E, Nurkolis F, Umaya C, Abdi Syahputra R (2024) Malaria's molecular dance: Mechanism, therapies, and emerging insights. Pharmacia 71: 1-12. https://doi.org/10.3897/pharmacia.71.e117145
Figure 2 Life cycle of Malaria.
Figure 2 from: Morales-Núñez AG, Larsen K, Cooke WJ (2016) Oahutanais makalii, a new genus and species of colletteid tanaidacean (Crustacea, Peracarida) from shelf-waters off Hawaii, with a taxonomic key. Zoosystematics and Evolution 92(1): 1-12. https://doi.org/10.3897/zse.92.5581
Figure 2 - Oahutanais makalii gen. et sp. n., holotype female: dorsal view. Scale bar: 0.5 mm.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.